Key result
At depolarized membrane potentials, isoproterenol amplified the flecainide-induced reduction of V̇ max and squared conduction velocity, suggesting a synergy that could facilitate arrhythmogenesis.
Why the study?
Does isoproterenol potentiate flecainide-induced conduction slowing in canine Purkinje fibers at depolarized membrane potentials?
Does isoproterenol potentiate flecainide-induced conduction slowing in canine Purkinje fibers at depolarized membrane potentials?
Answers are grounded in this paper and cite their sources.
Isoproterenol amplifies flecainide-induced conduction slowing at depolarized membrane potentials, suggesting a mechanism for flecainide proarrhythmia in the setting of ischemia.
Background This study was undertaken to test the hypothesis that β-adrenergic stimulation in the setting of membrane depolarization will potentiate flecainide-induced conduction slowing. Methods and Results To elucidate the potential mechanism for the flecainide proarrhythmia observed in CAST, the voltage dependence of β-adrenergic modulation of impulse propagation in eight flecainide-superfused canine Purkinje fibers was examined with a dual-microelectrode technique. At physiological membrane potentials (V m ) ([K + ] o =5.4 μmol), 1 μmol flecainide decreased V̇ max from 698±55 to 610±72 V/s ( P =.003) and squared conduction velocity (θ 2 ) from 2.11±1.1 to 1.72±0.9 (m/s) 2 ( P =.001). With K + depolarization to V m =−70 mV, flecainide further reduced V̇ max from 306±101 to 245±65 V/s and θ 2 from 1.12±0.4 to 0.99±0.6 (m/s) 2 , producing a 2.0-mV hyperpolarizing shift of apparent Na + channel availability curves derived from θ 2 . The addition of 1 μmol isoproterenol to flecainide-superfused fibers at physiological V m increased θ 2 by 8% to 1.84±0.6 (m/s) 2 ( P <.01) without altering V̇ max . At −70 mV, the addition of isoproterenol magnified the flecainide-induced reduction of V̇ max an additional 24% to 185±52 V/s ( P <.01) and θ 2 by 17% to 0.82±0.5 (m/s) 2 ( P =.04), producing an additional 1.8-mV ( P =.002) and 1.9-mV ( P =.002) hyperpolarizing shift in the apparent Na + channel inactivation curves generated from V̇ max and θ 2 , respectively. At physiological V m , the action potential duration (APD 95 ) was reduced from 307±35 to 269±27 ms ( P <.001) by flecainide and subsequently to 217±4 ms ( P <.001) with isoproterenol addition. With 12 mmol/L K + , APD 95 decreased from 198±23 to 182±17 ms ( P =.005) with flecainide and to 164±10 ms ( P =.004) with isoproterenol. Conclusions At depolarized V m , isoproterenol amplified the flecainide-induced reduction of V̇ max and θ 2 , suggesting a further adrenergic-mediated reduction of Na + current. Consequently, the synergy between catecholamines and flecainide at depolarized V m and the shortened APD 95 could facilitate arrhythmogenesis in the presence of underlying ischemia.
No takes yet. Share an insight, caveat, or question.
Cragun et al. (1997) studied Flecainide proarrhythmia mechanism (n=8). Isoproterenol and Flecainide vs. Flecainide alone / baseline was evaluated on V̇ max and squared conduction velocity (θ 2) at depolarized Vm. At depolarized membrane potentials, isoproterenol amplified the flecainide-induced reduction of V̇ max and squared conduction velocity, suggesting a synergy that could facilitate arrhythmogenesis.
Synapse has enriched 10 related papers. Consider them for comparative context: